MedPath

Comparative efficacy study of topical finasteride in androgenic alopecia

Phase 3
Recruiting
Conditions
androgenic alopecia.
Androgenic alopecia
Registration Number
IRCT20191203045592N2
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
40
Inclusion Criteria

Men 18-40 years old with moderate to severe androgenic alopecia.
Patients should not be treated with oral finasteride or other anti-androgen therapy for the past 6 months.
Willingness to participate in the study and fill out the informed consent form.
Their diagnosis has been clinically proven and other causes of hair loss have been ruled out.

Exclusion Criteria

Patients with other types of alopecia such as alopecia areata or telogen effluvium.
Any serious systemic disease
Receiving systemic treatment for androgenic alopecia during the last 6 months.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hair count. Timepoint: At the start of study and 12 weeks later. Method of measurement: Scalp & Hair Polarizing HMS System (KC Technology Company; Korea).;Hair thickness. Timepoint: At the start of study and 12 weeks later. Method of measurement: Scalp & Hair Polarizing HMS System (KC Technology Company; Korea).;Patient's satisfaction score. Timepoint: at the end of 12th week. Method of measurement: The standardized 7 point rating scale (–3 = greatly decreased, –2 = moderately decreased, –1 = slightly decreased, 0 = no change, +1 = slightly increased, +2 = moderately increased, +3 = greatly increased).;Physician's assessment based on changes in standard photographs. Timepoint: at the end of 12th week. Method of measurement: The standardized 7 point rating scale (–3 = greatly decreased, –2 = moderately decreased, –1 = slightly decreased, 0 = no change, +1 = slightly increased, +2 = moderately increased, +3 = greatly increased).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath